These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2336462)

  • 1. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
    Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
    Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
    Nishita T
    Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeting therapy with a drug using temperature-sensitive liposomes entrapped antitumor drug together with localized hyperthermia].
    Ogawa Y; Toguchi H
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1127-33. PubMed ID: 2350189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth.
    Yatvin MB; Mühlensiepen H; Porschen W; Weinstein JN; Feinendegen LE
    Cancer Res; 1981 May; 41(5):1602-7. PubMed ID: 7194141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
    Iga K; Hamaguchi N; Igari Y; Ogawa Y; Gotoh K; Ootsu K; Toguchi H; Shimamoto T
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1203-7. PubMed ID: 2046024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hyperthermia on blood flow and cis-diamminedichloroplatinum(II) pharmacokinetics in murine mammary adenocarcinomas.
    Ausmus PL; Wilke AV; Frazier DL
    Cancer Res; 1992 Sep; 52(18):4965-8. PubMed ID: 1516052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
    Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
    Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of thermosensitive CDDP-liposomes on human osteosarcoma cells in culture.
    Hattori M; Matsui N; Ohta H; Otsuka T; Yamada K; Asai K; Kato T
    Nihon Seikeigeka Gakkai Zasshi; 1992 May; 66(5):476-84. PubMed ID: 1506744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
    Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
    Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
    Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
    Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
    Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
    Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
    Chelvi TP; Jain SK; Ralhan R
    Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA
    Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
    Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH
    Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.